REGULATORY T CELLS DELAY DISEASE PROGRESSION IN ALZHEIMER’S-LIKE PATHOLOGY
暂无分享,去创建一个
Nicolas Cagnard | Martin Holzenberger | S. Aid | G. Dorothée | M. Holzenberger | E. Piaggio | N. Cagnard | C. Dansokho | Eliane Piaggio | P. Aucouturier | Guillaume Dorothée | Pierre Aucouturier | T. Chaigneau | Cira Dansokho | Dylla Ait Ahmed | Saba Aid | Cécile Toly-Ndour | Thomas Chaigneau | Vanessa Calle | C. Toly‐Ndour | Vanessa Calle | Dylla Ait Ahmed | Dylla Ait Ahmed | Thomas Chaigneau
[1] C. Badoual,et al. Administration of Low Doses of IL‐2 Combined to Rapamycin Promotes Allogeneic Skin Graft Survival in Mice , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] B. Becher,et al. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. , 2008, Immunity.
[3] Masanori Kato,et al. Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases , 2002, Journal of Neuroimmunology.
[4] G. Dorothée,et al. MHC-Independent Genetic Factors Control the Magnitude of CD4+ T Cell Responses to Amyloid-β Peptide in Mice through Regulatory T Cell-Mediated Inhibition , 2011, The Journal of Immunology.
[5] J. Hardy,et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. , 2000, Nature.
[6] J. Hardy,et al. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease , 2000, Nature.
[7] C. Duyckaerts,et al. Alzheimer disease models and human neuropathology: similarities and differences , 2007, Acta Neuropathologica.
[8] S. Appel,et al. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis , 2011, Brain : a journal of neurology.
[9] E. Calabrese,et al. PD1 negative and PD1 positive CD4+ T regulatory cells in mild cognitive impairment and Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[10] M. Schwartz,et al. The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus , 2014, The EMBO journal.
[11] Tuan Leng Tay,et al. USP18 lack in microglia causes destructive interferonopathy of the mouse brain , 2015, The EMBO journal.
[12] M. Guillot-Sestier,et al. Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology , 2015, Neuron.
[13] J. Ritz,et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. , 2011, The New England journal of medicine.
[14] F. Carrat,et al. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. , 2011, The New England journal of medicine.
[15] M. Schwartz,et al. Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer's disease pathology , 2015, Nature Communications.
[16] Seth Love,et al. Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease , 2010, PloS one.
[17] Jun Tan,et al. Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology , 2008, Nature Medicine.
[18] H. Gendelman,et al. Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson’s Disease , 2010, The Journal of Immunology.
[19] E. Shevach. Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.
[20] Nathan D. Price,et al. IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque Burden and Worsening Cognitive Behavior , 2015, Neuron.
[21] N. Inestrosa,et al. Wnt Signaling in the Nervous System and in Alzheimer's Disease Inestrosa and Varela-nallar Inestrosa and Varela-nallar , 2022 .
[22] D. Ethell,et al. Aβ-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer's mice , 2006, Neurobiology of Disease.
[23] D. Geschwind,et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease , 2009, Nature Medicine.
[24] D. Klatzmann,et al. Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial. , 2013, The lancet. Diabetes & endocrinology.
[25] P. Scheiffele,et al. SAM68 Regulates Neuronal Activity-Dependent Alternative Splicing of Neurexin-1 , 2011, Cell.
[26] D. Ethell,et al. Aβ-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS , 2009, Neurobiology of Disease.
[27] T. Südhof,et al. Essential Roles in Synaptic Plasticity for Synaptogyrin I and Synaptophysin I , 1999, Neuron.
[28] C. Holmes,et al. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report , 2003, Nature Medicine.
[29] G. Pawelec,et al. Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.
[30] L. Stoltze,et al. Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration , 2007, Journal of Neuroimmunology.
[31] S. Beggs,et al. Sublime Microglia: Expanding Roles for the Guardians of the CNS , 2014, Cell.
[32] I. Ferrer,et al. Neuropathology and Pathogenesis of Encephalitis following Amyloid β Immunization in Alzheimer's Disease , 2004, Brain pathology.
[33] L. Mucke,et al. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. , 2001, Nature medicine.
[34] I. Amit,et al. Aging-induced type I interferon response at the choroid plexus negatively affects brain function , 2014, Science.
[35] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[36] J. Bluestone,et al. IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells , 2010, The Journal of experimental medicine.
[37] B. Dubois,et al. Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization , 2003, Neurology.
[38] V. Perry,et al. Microglial priming in neurodegenerative disease , 2014, Nature Reviews Neurology.
[39] Simon Heath,et al. Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis. , 2010, Journal of Alzheimer's disease : JAD.
[40] R. Motter,et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.
[41] Stefano Ruggieri,et al. A pilot study on the use of interferon beta-1a in early Alzheimer’s disease subjects , 2013, Journal of Neuroinflammation.
[42] D. Boraschi,et al. The interleukin-1 receptor family. , 2013, Seminars in immunology.
[43] R. Sperling,et al. Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. , 2003, The Journal of clinical investigation.
[44] T. Nomura,et al. Regulatory T Cells and Immune Tolerance , 2008, Cell.
[45] Ralph A. Nixon,et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease , 2000, Nature.
[46] P. S. St George-Hyslop,et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. , 2000, Nature.
[47] H. Weiner,et al. Aβ-induced meningoencephalitis is IFN-γ-dependent and is associated with T cell-dependent clearance of Aβ in a mouse model of Alzheimer's disease , 2006 .
[48] H. Weiner,et al. Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[49] D. Klatzmann,et al. The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases , 2015, Nature Reviews Immunology.